Cargando…
A Review of Recent Advances in the Treatment of Elderly and Poor Performance NSCLC
Until recently, chemotherapy has remained the mainstay of treatment for the majority of patients with advanced non-small cell lung cancer (NSCLC). Excellent responses have been observed with immune-checkpoint inhibitors, and targeted treatments for those tumours with actionable mutations, resulting...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6070834/ https://www.ncbi.nlm.nih.gov/pubmed/30021993 http://dx.doi.org/10.3390/cancers10070236 |